The stock is on track for its best performance since May 21, 2021, when it gained 127%. Source link
Home/Market/Annovis Bio’s stock rockets 119% after reporting positive data in Parkinson’s disease trial Market Annovis Bio’s stock rockets 119% after reporting positive data in Parkinson’s disease trial NEW YORK DIGITAL MAGAZINE2 July 2024 112 Less than a minute Facebook Twitter LinkedIn Tumblr Pinterest Reddit WhatsApp The stock is on track for its best performance since May 21, 2021, when it gained 127%. Source link NEW YORK DIGITAL MAGAZINE2 July 2024 112 Less than a minute Facebook Twitter LinkedIn Tumblr Pinterest Reddit WhatsApp Share Facebook Twitter LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print